ASTeCC Incubator Companies
Adaptive Intelligent Systems and Biological Prospects, LLC
Advanced Semiconductor Processing Technology
Zhi David Chen
Based on research by Zhi David Chen, Center for Nanoscale Science & Engineering
Advanced Semiconductor Processing Technology’s current product is a dew point sensor which is based upon research on semiconductor processing technology and its applications on electronic devices including sensors and transistors. The company has also developed a new type of moisture sensor called alpha-Al2O3 based dew point.
Biological Prospects LLC
Patrick Lawless, 859.721.1412, firstname.lastname@example.org
Biological Prospects LLC develops and manufactures therapeutic natural products for the human and animal health markets. The company has commercialized a proprietary resveratrol product (Resverasyn®) with enhanced bioavailability and stability and which is free of the impurities present in natural sources of resveratrol. Biological Prospects currently is engaged in the research and development of plant-derived natural compounds with immunomodulatory, antimicrobial and anti-diabetic activities. The resulting technology will form the basis of the company’s second generation of innovative natural products with applications in a diverse array of industries.
BDC - Biomedical Development Corporation
Danika Lippert, Human Resources and Commercialization, 859.412.7650
Study our corporate DNA. You’ll see a biomedical research and development lab that fuses business with science. We form true partnerships with scientists, focus on superior clinical outcomes, and commercialize the innovative products that come from it. The result? Our products go from our lab. To the marketplace. To you.
Bluegrass Advanced Material, LLC
Nihar Shah, PhD, Chief Technology Officer, 859.257.0796
Based on research from the Center for Microelectrode Technology, Greg Gerhardt director, Peter Huettl assistant director
Developing a new generation of clinical diagnostic devices for patients with epilepsy and traumatic brain injury.
Todd Hastings, CEO, 859.576.4951
Dr. Sybille Muller, 859.533.7287
DermVantage is developing transfollicular delivery of biological agents for the cosmetic and medical industries. The company is exploring using its technology to treat hyperhidrosis and cancer.
Shannon Bass, President, 859.556.0731
Exatherm is developing a medical device that can apply heat to localized areas on patients to treat lung, colon, pancreatic and other forms of cancer. The process has been shown to selectively kill cancer cells and enhance the effects of certain chemotherapy drugs without damaging normal tissues. The company is planning a clinical trial with lung cancer patients at the University of Kentucky in late 2012 with a novel whole body circulatory hyperthermia system.
GISMO Therapeutic, Inc.
Hera Testing Labs, Inc.
Mukesh Agarwal, President, 216.496.9053
Invenio Therapeutics Inc. is an early-stage biopharmaceutical company developing novel drug compounds that terminally differentiate leukemia cells so that they no longer have the ability to divide and replicate. Invenio's focus is R&D on cutting-edge drug treatments targeting Acute Myeloid Leukemia (AML), for which no cure exists.
Minerva Systems & Technologies
Kalyan Ganesan, Chief Technology Officer, 859.489.0156 or 859.218.6569
Minerva Systems & Technologies, LLC is an emerging technology company with expertise in navigation and guidance, satellite & wireless communications, signal processing, and embedded hardware and software design and development.
Based on research by Patrick Sullivan / SCoBIRC and anatomy & neurobiology
R&D to control obesity using nanotechnology to alter the body's metabolic rate and increase the cell's ability to convert sugar to energy. Research could lead to future breakthroughs in the treatment of traumatic central nervous system damage and neurodegenerative disorders.
Based on research by John Littleton / molecular pharmacology and plant genomics
Commercialized technology that enables bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's current focus is on non-toxic insecticides, CNS-acting drugs and chemotherapeutic agents.
PowerTech Water, LLC
Redleaf Biologics, LLC
Science Tomorrow LLC
Signal Solutions LLC
Bruce F. O'Hara, 859.266.0964
Signal Solutions LLC was formed in February 2009 to sell products and support research associated with their non-invasive, high-throughput sleep-wake tracking system for mice. Currently, several systems are being used in research labs around the world including an 80 cage set-up at The Jackson Laboratory (Bar Harbor, ME) as part of a large-scale NIH U54 project to perform deep phenotyping on individual mouse gene knockouts to better understand these genes and associated diseases. Signal Solutions was chosen as a primary subcontractor for this five year effort referred to as KOMP2 and supported by the International Knockout Mouse Consortium. In April 2013, Signal Solutions was awarded a 2-year Phase I NIH SBIR grant to further extent the capability of its system to track REM and nonREM sleep in addition to other behaviors. Signal Solutions also develops a variety of other hardware and software for assessing physiological variables in mice, horses, and people.
Eric Ostertag, 859.218.6568
Vindico applies proprietary polymersome technology to develop and commercialize diagnostic and therapeutic applications focusing on the transfusion medicine market.
W-Z Biotech, founded in 2009 by Dr. Jay Zwischenberger, surgery, and Dr. Dongfang Wang, cardiothoracic surgery, specializes in the development of novel medical devices for cardiopulmonary surgery and hyperthermia delivery systems for lung cancer therapy.